Indometacin suppository

Developed for: acute pancreatitis · chronic pancreatitis
Investigated by: Affiliated Hospital of Yunnan University · Changhai Hospital · First People's Hospital of Hangzhou · LanZhou University · Peking Union Medical College Hospital · Qilu Hospital of Shandong University
+4 more
· Ruijin Hospital · Shanghai Pudong New Area Gongli Hospital · The Second Affiliated Hospital of Baotou Medical College · The Third Xiangya Hospital of Central South University

today NCT07202559 · not/applicable

20262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT07202559	Oct 2025 → Dec 2027 expected	acute pancreatitis, chronic pancreatitis	Changhai Hospital	Recruiting	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Indometacin suppository	ClinicalTrials.gov intervention name — accepted as the source's own label NCT07202559 ↗
Route	Rectal	“Administration of a 100mg indometacin suppository rectally 30 minutes prior to ESWL” NCT07202559 ↗